ĀÜĄņĀŅĀ×

Mace Rothenberg, MD, most recently served as as chief medical officer of Pfizer. He is a transformative leader who has built and led highly successful teams over a 30-year career spanning academia and the biopharmaceutical industry.

At Pfizer, Maceā€™s organization developed and obtained regulatory approval for an industry-leading 11 new cancer medicines. He is the recipient of the first Craig Saxton Lifetime Achievement Award from Pfizer for his success in cancer drug development.

Prior to joining Pfizer, he spent 25 years in academia, with significant accomplishments including serving as Principal Investigator on clinical trials, tripling the size of the clinical programs, and mentoring dozens of early career clinical and translational researchers. Mace has served on the faculties of the University of Texas Health Science Centerā€“San Antonio and Vanderbilt University Medical Center and was named the 2020 Mitchell Blutt Visiting Professor for Entrepreneurism and Medicine at the Perelman School of Medicine of the University of Pennsylvania. He was also the recipient of the Lane W. Adams Quality of Life Award from the American Cancer Society and the Statesman Award from the American Society of Clinical Oncology for his years of service to cancer patients.

Mace is a member of the American College of Physicians and the American Society of Clinical Oncology and is board-certified in Internal Medicine and Medical Oncology. Mace is a graduate of the New York University School of Medicine, completed his residency in Internal Medicine at Vanderbilt University and his fellowship in Medical Oncology at the National Cancer Institute.